Publications by authors named "Jacob Appelbaum"

Claim this Profile
P
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During Treatment.
Matthew Wu, Kathryn Russell, Carole M Shaw, Anna B Halpern, Cristina Ghiuzeli, Jacob S Appelbaum

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy.
Hannah R Abrams, Helene Starks, Lindsey Bandini, Terry Harrington, Mary-Elizabeth M Percival, Jacob Appelbaum

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm.
Suravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, Kim Quach, Eva Gill, Jacob S Appelbaum

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy.
Suravi Raychaudhuri, Megan Othus, Mary-Elizabeth M Percival, Guillermo Garcia-Manero, Frederick R Appelbaum, Jacob S Appelbaum

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report.
Meghan Wallace, Bruce Mathey, Cecilia C S Yeung, Jacob S Appelbaum, Mark Wallace

Case Rep Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Natalie Wuliji, Salene M W Jones, Ted Gooley, Aaron T Gerds, Bruno C Medeiros, Jacob Appelbaum, Frederick R Appelbaum

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cure for the kiss of death?
Jacob S Appelbaum, Mary-Elizabeth Percival, Bart L Scott

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples.
Suravi Raychaudhuri, Hakan Gem, Kevin Chung, Jeffrey S McLean, Kristopher A Kerns, Jacob B Appelbaum

NPJ Biofilms Microbiomes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.
Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, Harry P Erba, Eliana Dietrich, Jacob Appelbaum

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.
Khushboo V Pal, Megan Othus, Zahra Ali, Katherine Russell, Carole Shaw, Jacob S Appelbaum

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second chances for secondary AML.
Jacob S Appelbaum, Frederick R Appelbaum, Mary-Elizabeth Percival

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing.
Jacob Appelbaum, April E Price, Kaori Oda, Joy Zhang, Wai-Hang Leung

J Clin Invest· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing S Tiong, Chong Chyn Chua

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time independent factors that predict relapse in adults with acute myeloid leukemia.
John J Lim, Megan Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context-specific synthetic T cell promoters from assembled transcriptional elements.
Jacob Appelbaum, Jia Wei, Rithun Mukherjee, Taylor Ishida, James Rosser

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Jacob S Appelbaum

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms.
Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob Appelbaum

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents.
Michelle Y Zhang, Megan Othus, Carole Shaw, Kelda G Schonhoff, Anna B Halpern, Jacob Appelbaum

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.
Noam E Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Jacob Appelbaum

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms.
Gabrielle Paras, Megan Othus, Kelda Schonhoff, Carole Shaw, Mohamed Sorror, Jacob Appelbaum

Leukemia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia.
Jacob Appelbaum, Donald M Arnold, John G Kelton, Terry Gernsheimer, Stefan D Jevtic

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy.
Utkarsh H Acharya, Tejaswini Dhawale, Seongseok Yun, Caron A Jacobson, Julio C Chavez, Jacob Appelbaum

Expert Rev Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy.
Jacob S Appelbaum, Filippo Milano

Curr Hematol Malig Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.
Jacob Appelbaum, David Wells, Joseph B Hiatt, Gideon Steinbach, F Marc Stewart

J Immunother Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis